期刊文献+

糖尿病肾病患者血清半胱氨酸蛋白酶抑制剂C、脂蛋白(α)和超敏C反应蛋白的检测及其临床意义 被引量:7

Clinical significance of determination of serum cystatin C,lipoprotein (α) and high sensitivity C-reactive protein in type 2 diabetic patients with early renal impairment.
下载PDF
导出
摘要 目的检测2型糖尿病患者血清中半胱氨酸蛋白酶抑制剂C(CysC)、脂蛋白(α)[LP(α)]和超敏C反应蛋白(hs-CRP)水平,并探讨其临床意义。方法 126例2型糖尿病患者分为单纯糖尿病组(DM组)40例、早期糖尿病肾病组(EDN组)44例、临床糖尿病肾病组(DN组)42例,以70例健康体检者作为对照组,采用BECKMAN UniCel Dxc600全自动生化分析仪分别检测血清中的CysC、LP(α)以及hs-CRP水平。结果 2型糖尿病患者中CysC、LP(a)、hs-CRP水平均高于正常对照组(P<0.01),临床糖尿病肾病组患者的CysC、LP(a)、hs-CRP水平也明显高于单纯糖尿病组和早期糖尿病肾病组(P<0.01),在2型糖尿病患者中,血清中的CysC、LP(α)、hs-CRP与尿微量白蛋白(mALB)呈正相关,联合检测CysC、LP(α)、hs-CRP对糖尿病肾病的阳性率达88.5%。结论 CysC、LP(α)、hs-CRP作为诊断糖尿病早期肾损害的敏感指标,联合检测更具实用价值。 Objective To study the clinical significance of measurement of serum cystatin C (Cysc), lipopmtein α (LPα) and high sensitivity C -reactive protein (hs - CRP) in type 2 diabetic mellitus (T2DM)patients with early renal impairment. Methods One hundred and twenty six patients were divided into three groups: 40 cases in simple diabetic group (DM), 44 cases in early diabetic nephmpathy group (EDN) and 42 cases in clinical diabetic nephropathy group ( DN), and 70 healthy persons were chosen as normal control group. Serum levels of Cysc, LP (α) and hs - CRP were detected by BECKMAN UniCel Dxc600 automatic biochemistry analyzer. Results Serum levels of Cysc, LP (α) and hs - CRP in T2DM patients were higher than those of normal control group ( P 〈0.01 ), they were also significantly higher in DN group than in DM group and EDN group ( P 〈 0.01 ). The serum levels of Cysc, LP (α) and hs - CRP were positively correlated with urinary mALB in T2DM patients. Conclusion Serum levels of Cysc, LP (α) and hs - CRP are sensitive indicators for detection of early renal impairment in patients with type 2 diabetes mellitus.
出处 《临床和实验医学杂志》 2010年第13期961-963,共3页 Journal of Clinical and Experimental Medicine
关键词 糖尿病肾病 半胱氨酸蛋白酶抑制剂C 脂蛋白(Α) 超敏C反应蛋白 Diabetic nephropathy Cystatin C Lipoprotein(α) High -sensitivity c -reactive protein
  • 相关文献

参考文献10

二级参考文献22

  • 1[1]Russell TA.Diabetic nephropathy in patients with type 1 diabetes mellitus[J].Nephrol Ners J,2006,33(1):15-28.
  • 2[2]Hovind P,Rossing P,Tarnow L,et al.Progression of diabetic nephropathy[J].Kidney Int,2001,59:702-709.
  • 3[4]Cooper MR and Jandeleit-Dahm KA.Lipids and diabetic renal disease[J].Curr Dia Rep.2005,5(6):445-448.
  • 4[6]Caramori ML,Kim Y,Huang C,et al.Cellular basis of diabetic nephropathy[J].Diabetes,2002,51:506-513.
  • 5[7]Basi S,Lewis JB.Microalbuminuria as a target to improve cardiovascular and renal outcomes[J].Am J kidney Dis,2006,47(6):927-946.
  • 6Andersen JK,Schmidt C,Nordin G.Serum cystatin C.determined by a rapid,automated particle-enhanced turbidimetric method,is a better marker than serum cretinine for glomerular filtration rate.Clin Chem,1994,40(10):1921-1926.
  • 7Randers E,Erlandsen EJ.Serum cystatin C as endogenous marker of the renal function-a review.ClinChem Lab Med,1999,37(4):389-395.
  • 8keevil GB,Kilpatrick ES,Nichols SP,et al.Biological variation of cystatin C:implication for the assessnent of glomerular filtration rate.Clin chem.1998,44(7):1535-1539.
  • 9Finney H,Newman DJ,Gruber W.Initial evaluatin of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems(BNA,BN Ⅱ).Clin Chem,1997,43(6):1016-1020.
  • 10Cabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 1999,340:448-454.

共引文献416

同被引文献57

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部